Pilot Study to Evaluate the Benefits and the Risks of Methylphenidate for the Treatment of Cocaine Dependence

Trial Profile

Pilot Study to Evaluate the Benefits and the Risks of Methylphenidate for the Treatment of Cocaine Dependence

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 26 Jul 2018

At a glance

  • Drugs Methylphenidate (Primary)
  • Indications Cocaine abuse
  • Focus Therapeutic Use
  • Acronyms ANRS STIMAGO
  • Most Recent Events

    • 19 Jul 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
    • 16 Mar 2018 Planned End Date changed from 26 May 2018 to 30 Mar 2019.
    • 16 Mar 2018 Planned primary completion date changed from 26 Feb 2018 to 31 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top